AI In Drug Discovery: Accelerating The Development Of New Medicines
Year: 2026
Type: article
Abstract: Artificial Intelligence (AI) has emerged as a transformative tool in the pharmaceutical industry, significantly accelerating the process of drug discovery and development. Traditional drug discovery methods are time-consuming, expensive, and often associated with high failure rates. The integration of Artificial Intelligence techniques such as machine learning, deep learning, and natural language processing has revolutionized target identification, lead optimization, and clinical trials. AI enables rapid analysis of large datasets, prediction of drug-target interactions, and identification of novel therapeutic candidates. This review highlights the role, applications, advantages, and challenges of AI in drug discovery and its future prospects in developing new medicines.
Author: Ayush Gupta
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7155102116
